169 related articles for article (PubMed ID: 7790105)
1. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.
Summersgill JT; Sahney NN; Gaydos CA; Quinn TC; Ramirez JA
Infect Immun; 1995 Jul; 63(7):2801-3. PubMed ID: 7790105
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism.
Mehta SJ; Miller RD; Ramirez JA; Summersgill JT
J Infect Dis; 1998 May; 177(5):1326-31. PubMed ID: 9593020
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.
Pantoja LG; Miller RD; Ramirez JA; Molestina RE; Summersgill JT
Infect Immun; 2001 Dec; 69(12):7927-32. PubMed ID: 11705979
[TBL] [Abstract][Full Text] [Related]
4. Restriction of Chlamydia pneumoniae replication in human dendritic cell by activation of indoleamine 2,3-dioxygenase.
Njau F; Geffers R; Thalmann J; Haller H; Wagner AD
Microbes Infect; 2009 Nov; 11(13):1002-10. PubMed ID: 19643200
[TBL] [Abstract][Full Text] [Related]
5. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells.
Quinn TC; Gaydos CA
Am Heart J; 1999 Nov; 138(5 Pt 2):S507-11. PubMed ID: 10539860
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells.
Byrne GI; Ouellette SP; Wang Z; Rao JP; Lu L; Beatty WL; Hudson AP
Infect Immun; 2001 Sep; 69(9):5423-9. PubMed ID: 11500413
[TBL] [Abstract][Full Text] [Related]
7. Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon.
Shemer-Avni Y; Wallach D; Sarov I
Infect Immun; 1989 Nov; 57(11):3484-90. PubMed ID: 2509363
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha.
Ishihara T; Aga M; Hino K; Ushio C; Taniguchi M; Iwaki K; Ikeda M; Kurimoto M
Biomed Res; 2005 Aug; 26(4):179-85. PubMed ID: 16152734
[TBL] [Abstract][Full Text] [Related]
9. Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.
Bellmann-Weiler R; Martinz V; Kurz K; Engl S; Feistritzer C; Fuchs D; Rupp J; Paldanius M; Weiss G
Immunobiology; 2010; 215(9-10):842-8. PubMed ID: 20646782
[TBL] [Abstract][Full Text] [Related]
10. Role of the nitric oxide synthase pathway in inhibition of growth of interferon-sensitive and interferon-resistant Rickettsia prowazekii strains in L929 cells treated with tumor necrosis factor alpha and gamma interferon.
Turco J; Winkler HH
Infect Immun; 1993 Oct; 61(10):4317-25. PubMed ID: 7691748
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently.
Currier AR; Ziegler MH; Riley MM; Babcock TA; Telbis VP; Carlin JM
J Interferon Cytokine Res; 2000 Apr; 20(4):369-76. PubMed ID: 10805371
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.
Pantoja LG; Miller RD; Ramirez JA; Molestina RE; Summersgill JT
Infect Immun; 2000 Nov; 68(11):6478-81. PubMed ID: 11035763
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase.
Adams O; Besken K; Oberdörfer C; MacKenzie CR; Rüssing D; Däubener W
Microbes Infect; 2004 Jul; 6(9):806-12. PubMed ID: 15374002
[TBL] [Abstract][Full Text] [Related]
14. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus.
Feduchi E; Alonso MA; Carrasco L
J Virol; 1989 Mar; 63(3):1354-9. PubMed ID: 2536838
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan protects human melanoma cells against gamma-interferon and tumour necrosis factor-alpha: a unifying mechanism of action.
Wood JM; Ehrke C; Schallreuter KU
Melanoma Res; 1991; 1(3):177-85. PubMed ID: 1668725
[TBL] [Abstract][Full Text] [Related]
16. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages.
Carlin JM; Borden EC; Byrne GI
J Interferon Res; 1989 Jun; 9(3):329-37. PubMed ID: 2501398
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of tumor necrosis factor-alpha and interferon-gamma on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8).
Nanes MS; McKoy WM; Marx SJ
Endocrinology; 1989 Jan; 124(1):339-45. PubMed ID: 2491807
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.
Manor E; Sarov I
Infect Immun; 1990 Jun; 58(6):1886-90. PubMed ID: 2111286
[TBL] [Abstract][Full Text] [Related]
19. Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection.
Sakash JB; Byrne GI; Lichtman A; Libby P
Infect Immun; 2002 Jul; 70(7):3959-61. PubMed ID: 12065543
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture.
Mannonen L; Kamping E; Penttilä T; Puolakkainen M
Microb Pathog; 2004 Jan; 36(1):41-50. PubMed ID: 14643639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
